Replies to post #72404 on NorthWest Biotherapeutics Inc (NWBO)

[TC_Trader]

Logging off now will look more in depth in about 8 hours when I am at work.

[flipper44]

I'm all for people getting rich, but unless I'm mistaken, the corporate rules only allow so many board members to be voted in or out each year, so is it fair to say there is not another potential decisive proxy fight in the offing (none transpired last year), particularly with a higher board count this year than last?

[maverick_1]

Latest Mav_1 Computations Woodford holdings July 31st ~29.61 mln shs based on below calculations from Woodford's websiteS vs June 30 nasdaq.com of 25.9 mln : suggests +3.7 mln IF calculations are correct for month of July

1)From Woodford Equity Income Fund July 31st:

61st Northwest Biotherapeutics Health Care 0.26%

https://woodfordfunds.com/our-funds/wpct/fullportfolio/
Fund Size was UK$9.16 bln or US$12.119 Bln
UK lb to $US closed at 1.3233
NWBO closed July 29 (last trading day@) 0.444
Woodford Patient Equity NWBO shrs ~ 27.294 mln July 29, 2016

2)From Woodford Patient Capital Trust July 31st

61 Northwest Biotherapeutics Health Care 0.26%

Fund Size: UK lb 777 mln or US$1.028 Bln
Woodford Patient Capital Trust ~2.316 mln NWBO shrs

3)Combining Woodford Equity Income Fund + Woodford Patient Capital Trust results in 29.61 Mln NWBO shs July 31st.

CONTRASTED to: Nasdaq.com
WOODFORD INVESTMENT MANAGEMENT LLP 06/30/2016 25,915,937 NWBO shs.

TO DO:
1)Folks should verify the above calculations independent of my own: I can make a mistake!
2)IF my calculations are correct it raises the following question solely for Woodford's Investment Funds:
When legally do FOREIGN (non US institutions) need to file a revised 13D holder's change in holdings, and I think there is another category for >10% holders.
3) Capita Financial Mgrs (Multiple Portfolios) holding of 18.3 mln (WHO ARE THEY; LOCATION; Investment Portfolio MgrS) All this NEEDS to be put in perspective to Woodford's holdings